` 600285 (Henan Lingrui Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

600285
vs
S
Shanghai Composite

Over the past 12 months, Henan Lingrui Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +10% compared to the Shanghai Composite's +25% growth.

Stocks Performance
600285 vs Shanghai Composite

Loading
600285
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600285 vs Shanghai Composite

Loading
600285
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
600285 vs Shanghai Composite

Loading
600285
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Henan Lingrui Pharmaceutical Co Ltd vs Peers

Shanghai Composite
600285
JEF
JNJ
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Henan Lingrui Pharmaceutical Co Ltd
Glance View

Market Cap
12.9B CNY
Industry
Pharmaceuticals

Nestled in the heart of China's Henan province, Henan Lingrui Pharmaceutical Co Ltd has quietly crafted a legacy in the pharmaceutical sector, blending traditional Chinese medicine with modern medical practices. Founded in an environment rich in natural resources, the company takes pride in its extensive portfolio that includes a broad range of pharmaceutical products such as tablets, injections, ointments, and Chinese patent medicines. The company's approach is an intricate dance between ancient wisdom and contemporary science, where herbal remedies are often synthesized with cutting-edge pharmaceutical manufacturing processes. Priding itself on research and development, Lingrui regularly collaborates with esteemed medical institutions, ensuring that its offerings remain both innovative and deeply rooted in traditional therapeutic principles. The financial heartbeat of Henan Lingrui is sustained through a strategic balance of domestic sales and international exports, capitalizing on the rising global demand for natural and alternative medicines. As the company expands its footprint, it continues to harness its robust supply chain and distribution channels to seamlessly deliver its products to hospitals, pharmacies, and health institutions across various regions. Indeed, the harmonious blend of traditional and modern methodologies not only defines Lingrui's operations but also shapes its revenue streams. By adhering to stringent quality standards and fostering partnerships, Henan Lingrui Pharmaceutical not only thrives in its local market but also competes in diverse international arenas, leveraging its unique product offerings as a cornerstone for financial growth.

Intrinsic Value
28.83 CNY
Undervaluation 21%
Intrinsic Value
Price
Back to Top